Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 56

1.

Epstein-Barr virus-encoded LMP1 and CD40 mediate IL-6 production in epithelial cells via an NF-kappaB pathway involving TNF receptor-associated factors.

Eliopoulos AG, Stack M, Dawson CW, Kaye KM, Hodgkin L, Sihota S, Rowe M, Young LS.

Oncogene. 1997 Jun 19;14(24):2899-916.

2.

LMP1 TRAFficking activates growth and survival pathways.

Soni V, Cahir-McFarland E, Kieff E.

Adv Exp Med Biol. 2007;597:173-87. Review.

PMID:
17633026
3.

Epstein-barr virus transformation: involvement of latent membrane protein 1-mediated activation of NF-kappaB.

Cahir McFarland ED, Izumi KM, Mosialos G.

Oncogene. 1999 Nov 22;18(49):6959-64. Review.

4.

[Signal transduction and biological characteristics of EB virus-encoded latent membrane protein 1 and its correlation with CD40].

Tao Y, Zhang XG.

Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2004 Oct;26(5):585-90. Review. Chinese.

PMID:
15562778
5.

The role of Epstein-Barr virus in neoplastic transformation.

Knecht H, Berger C, Rothenberger S, Odermatt BF, Brousset P.

Oncology. 2001;60(4):289-302. Review.

PMID:
11408795
7.

CD40-mediated signaling in B cells. Balancing cell survival, growth, and death.

Kehry MR.

J Immunol. 1996 Apr 1;156(7):2345-8. Review.

PMID:
8786287
8.

Early events in TNF signaling: a story of associations and dissociations.

Darnay BG, Aggarwal BB.

J Leukoc Biol. 1997 May;61(5):559-66. Review.

PMID:
9129204
9.

Role of the Epstein-Barr virus-encoded latent membrane protein-1, LMP1, in the pathogenesis of nasopharyngeal carcinoma.

Morris MA, Dawson CW, Young LS.

Future Oncol. 2009 Aug;5(6):811-25. doi: 10.2217/fon.09.53. Review.

PMID:
19663731
10.

[Anti-apoptotic function of the Epstein-Barr virus LMP1 and BHRF1 proteins].

Kawanishi M.

Nihon Rinsho. 1996 Jul;54(7):1848-54. Review. Japanese.

PMID:
8741677
11.

The role of the EBV-encoded latent membrane proteins LMP1 and LMP2 in the pathogenesis of nasopharyngeal carcinoma (NPC).

Dawson CW, Port RJ, Young LS.

Semin Cancer Biol. 2012 Apr;22(2):144-53. doi: 10.1016/j.semcancer.2012.01.004. Epub 2012 Jan 12. Review.

PMID:
22249143
12.

TRAF-mediated regulation of immune and inflammatory responses.

Wang Y, Zhang P, Liu Y, Cheng G.

Sci China Life Sci. 2010 Feb;53(2):159-68. doi: 10.1007/s11427-010-0050-3. Epub 2010 Mar 7. Review.

PMID:
20596822
13.

NF-κB and IRF7 pathway activation by Epstein-Barr virus Latent Membrane Protein 1.

Ersing I, Bernhardt K, Gewurz BE.

Viruses. 2013 Jun 21;5(6):1587-606. doi: 10.3390/v5061587. Review.

14.

The Latent Membrane Protein 1 (LMP1).

Kieser A, Sterz KR.

Curr Top Microbiol Immunol. 2015;391:119-49. doi: 10.1007/978-3-319-22834-1_4. Review.

PMID:
26428373
15.

Cell survival and death program modulated by LMP1: implication in antitumor immunity.

Zhang XN, Huang PC.

Ai Zheng. 2009 Aug;28(8):831-7. Review.

PMID:
19664329
16.

[Regulation of apoptosis by the latent infection membrane protein 1 of Epstein-Barr virus].

Kawanishi M.

Nihon Rinsho. 1997 Feb;55(2):305-10. Review. Japanese.

PMID:
9046815
17.

Differential B-lymphocyte regulation by CD40 and its viral mimic, latent membrane protein 1.

Graham JP, Arcipowski KM, Bishop GA.

Immunol Rev. 2010 Sep;237(1):226-48. doi: 10.1111/j.1600-065X.2010.00932.x. Review.

PMID:
20727039
18.
19.

Protein-protein interactions in TRAF3.

Ely KR, Kodandapani R, Wu S.

Adv Exp Med Biol. 2007;597:114-21. Review.

PMID:
17633021
20.

CD40 and the effect of anti-CD40-binding on human multiple myeloma clonogenicity.

Tong AW, Stone MJ.

Leuk Lymphoma. 1996 Mar;21(1-2):1-8. Review.

PMID:
8907262

Supplemental Content

Support Center